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Abstract
TRANSPATH can either be used as an encyclopedia, for both speciﬁc and general
information on signal transduction, or can serve as a network analyser. Therefore,
three modules have been created: the ﬁrst one is the data, which have been manually
extracted, mostly from the primary literature; the second is PathwayBuilder,
which provides several different types of network visualization and hence faciliates
understanding; the third is ArrayAnalyzer, which is particularly suited to gene
expression array interpretation, and is able to identify key molecules within signalling
networks (potential drug targets). These key molecules could be responsible for
the coordinated regulation of downstream events. Manual data extraction focuses
on direct reactions between signalling molecules and the experimental evidence for
them, including species of genes/proteins used in individual experiments, experimental
systems, materials and methods. This combination of materials and methods is
used in TRANSPATH to assign a quality value to each experimentally proven
reaction, which reﬂects the probability that this reaction would happen under
physiological conditions. Another important feature in TRANSPATH is the inclusion
of transcription factor–gene relations, which are transferred from TRANSFAC,
a database focused on transcription regulation and transcription factors. Since
interactions between molecules are mainly direct, this allows a complete and
stepwise pathway reconstruction from ligands to regulated genes. More information is
available at www.biobase.de/pages/products/databases.html. Copyright  2004 John
Wiley & Sons, Ltd.
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Introduction
Uncovering cellular processes under normal condi-
tions will improve our understanding of pathologi-
cal situations. Key components of the cellular net-
work are potential drug target candidates and better
knowledge about cellular processes will help us to
learn more about possible side-effects. However,
cellular networks are highly connected and com-
plex, thus understanding them is a challenging task.
Several distinct approaches are currently used
to identify molecular interactions within the cell.
The classical method used by most molecular biol-
ogy laboratories in the past was the investiga-
tion of single steps within the network. Gener-
ally these data are of high quality, since con-
trols have been conducted for individual interac-
tion results. However, this approach is not suited
to the generation of holistic knowledge of cellular
processes. More recently, high-throughput exper-
iments have been developed that produce large
masses of data, the most widely used methodolo-
gies being the yeast two-hybrid method [5,15], 2D-
gel protein assays [4] and gene expression arrays
Copyright  2004 John Wiley & Sons, Ltd.164 C. Choi et al.
[2]. Storage of these data in appropriate reposito-
ries is an absolute prerequisite for making the best
use of existing research results to achieve system-
atic computational network analysis and to interpret
these data with regard to their biological meaning.
One approach for creating such databases that has
been investigated is automatic text mining [12]. So
far, this approach seems to be limited by several
problems: e.g. protein identiﬁcation is ambiguous
because of the lack of a generally used terminol-
ogy in the past; also, research language is hetero-
geneous and negations are not always interpreted
correctly. Moreover, the relevant information may
be extremely fragmented within individual, or even
between several, publications. However, automatic
text mining may provide mass information, albeit
with lower quality and depth than data extraction
by expert biologists. With the aim of achieving
more reliable data, several interaction databases
have been initiated, such as DIP [18], BIND [1] and
aMAZE [16], where interactions have been inferred
mostly by high-throughput experiments and mainly
on yeast species. Databases concentrating more on
human or mammalian proteins are CSNDB [14],
TRANSPATH [6,8,13] and MINT [19]. Among
these, TRANSPATH seems to contain the high-
est number of mammalian data points, in relative
terms as well as in absolute numbers: over 72%
of all so-called ‘basic’ molecules are mammalian
proteins, of which about 2400 are human molecules
(see Figure 1). In contrast to most of the databases
mentioned above, most reactions in TRANSPATH
are directed, and hence allow upstream and down-
stream queries, as well as describing the func-
tion of the reaction (activation vs. inhibition). Fur-
thermore, direct interactions between molecules
are described, allowing the construction of step-
wise and coherent pathways. TRANSPATH also
includes quality criteria, which are outlined below.
It is clear that we can beneﬁt from integrating
all of the major databases; their combined strength
might consist in different depths of detail, simply
more data on protein interactions (better coverage)
or other aspects. The integration of TRANSFAC
[10] and TRANSPATH is a good example for
yielding beneﬁts (see below). In the end more
complete and broad cellular pathway knowledge
will be gained.
Currently a public demo version of TRANS-
PATH is available at www.biobase.de/pages/
products/transpath.html comprising the pathway
Figure1. TRANSPATH concentrateson mammaliandata.
Release 4.3 (October 2003) contains about 2400 human
proteins, 34% of all basic proteins in the database; 70% of
the basic proteins are either human, mouse or rat
of interleukin-1 (IL-1), a pro-inﬂammatory cyto-
kine important in the innate immune response. This
extract from TRANSPATH professional contains
>600 interactions and >800 signalling molecules,
mainly from mammalian organisms (which com-
prise 4% and 6% of TRANSPATH Professional
4.3, respectively).
Database structure
We segmented signal transduction into three
major functional units: signalling components
called ‘molecules’, interactions connecting these
molecules called ‘reactions’, and ‘genes’ to
differentiate transcriptional regulation of genes and
protein interactions [8]. They are connected by
a bipartite directed graph, the nodes alternately
representing molecules and reactions, genes being
treated as a subset of molecules. As of October
2003, TRANSPATH Professional release 4.3
contains about 13800 molecules, >3800 genes
and >17000 reactions collected from about
6500 references. Updates are released quarterly.
Molecule and gene entries contain, among other
information, cross-references to numerous other
information resources, such as TRANSFAC,
SwissProt, EMBL, LocusLink, Affymetrix chips,
OMIM, InterPro and GO. For some of the
reactions, links have been made to DIP and BIND
(200 and 20, respectively). Data are extracted
mainly from the primary literature by expert
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biologists. During the curation process the database
curator specializes in speciﬁc topics in order
to produce coherent networks in the database.
Finalizing one speciﬁc topic will result in so-called
‘clickable maps’, summarizing expert knowledge
into one cartoon, from which molecule entries are
directly accessible.
Because protein constructs used in experiments
are often from different species or are not indicated
in primary papers, the problem arises that complete
pathways cannot be constructed for a single species
unless we combine the knowledge obtained from
material of different species. Therefore we intro-
duced a hierarchical representation for molecules
and distinct types of reactions. For molecule entries
in TRANSPATH the lowest level corresponds to
the speciﬁc molecules of a particular species, which
are referred to as ‘basic’-type molecules. The sec-
ond level, named ‘orthologue’-type molecules, is
represented by generic entries, to which all of the
corresponding orthologous basic entries are linked.
This hierarchical structure enables abstractions in
order to reﬂect interactions from several species to
a more general signalling network.
Reaction entries also exist on two main levels
of detail: ‘mechanistic’ reactions, which represent
the mechanism of reactions and usually connect
basic molecules, and ‘semantic’ ones, which depict
direction and function of the reaction occurring
between ‘orthologue’ molecules and hence pool
information from speciﬁc ‘mechanistic’ reactions
to show the signal ﬂow in a more general manner.
That way high connectivity is guaranteed with
semantic reactions and detailed information can be
obtained from mechanistic reactions.
Quality assurance
Mass data in terms of protein interactions are
already available (see Introduction). The remaining
challenge is to structure these data to get biologi-
cally relevant answers. In our approach we rely on
high quality data.
We concentrate on manual data extraction of
primary publication papers particularly including
data from individual or ‘small-scale experiments’
in contrast to high-throughput data or results
from ‘large-scale experiments’, which often do not
depict physiological conditions [3]. Manual read-
ing and extraction of the data also enables us to
pick up detailed information, in particular experi-
mental conditions. In order to assess the relevance
of a reaction for the physiological situation and the
immediacy of the interaction between the reported
molecules, we developed a quality scale system.
Two aspects are integrated into our quality scale
system: the material that has been used and the
method that has been applied in a reported exper-
iment to prove a certain reaction. For each com-
bination of material and method we have set a
‘reliability value’ to assign a conﬁdence level to
each reaction (see Figure 2a).
During the validation process for these reliability
values, a trade-off has been made between evidence
of a direct interaction and physiological conditions.
Detection of direct interactions is necessary for
understanding the pathway in a stepwise manner,
whereas physiological conditions refer to the rel-
evance of a proven direct interaction in vivo.D i f -
ferences in the physiological relevance arise, e.g.
by in vitro translated material vs. correctly folded,
naturally occurring, endogenous proteins.
While extracting information from a scientiﬁc
paper, the origin of molecules and the methods
used for proving a reaction between molecules
are stored, from which the reliability value will
be automatically assigned in the ‘quality’ ﬁeld.
By this means network analysis can be viewed
and ﬁltered according to the reliability of the
underlying experimental evidences. The assigned
reliability values have been revised by molecular
biologists. If the user is not in agreement with
our reliability values, he/she can change the values
in the menu ‘edit the quality reaction matrix’
according to his own knowledge. These values
will appear in the reaction table in addition to the
preset ones. Along with this, a quality assessment
of the experimental system, i.e. the cell lines or
tissues used, is recorded. Furthermore, reactions in
TRANSPATH are often proved independently by
several papers, which also conﬁrms the reliability
of a reaction (see Figure 2b).
One other quality criterion of TRANSPATH is
that species information of the interacting proteins
is retained (see Figure 1), which is not the case
in other databases, such as HPRD [11], where
interactions reported for distinct species are all
represented as part of the human network. Previous
articles often have to be consulted to retrieve the
species information, or the authors have to be
contacted directly. This distinction is necessary,
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(a)
(b)
Figure 2. Quality assessment in TRANSPATH. (A) Integration of data about the speciﬁc experimental conditions.
Depending on the biological material and method applied in the experiment, the reaction is more or less likely to happen
in the cell and organism. Therefore, we listed material sources and methods crucial for signal transduction and assigned
reliability values (scale 1–5) for each combination of material and method (quality matrix). This value is provided in the
reaction entry. (B) Frequency of evidences. About one-third of experimentally proven reactions are identiﬁed by more
than one experiment, usually conducted using different methods by different research groups, and hence these reactions
a r em o r el i k e l yt oo c c u rin vivo
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since it has been shown that orthologous proteins
may exert different functions in different species
[17]. Storing species details thus enables ﬁltering in
network visualization and viewing of discrepancies
in signalling between different species.
TRANSPATH is also integrated with TRANS-
FAC [10], a database focused on transcriptional
regulation. This allows the acquisition of high-
quality data for a complete stepwise signalling
pathway from ligand to gene. Hence, signalling
network analysis can be directed towards transcrip-
tional regulation or protein networks.
Network analysis
For drug target identiﬁcation it is crucial to gain
knowledge on signalling networks and their key
signalling components. With TRANSPATH,t a r -
get genes or key regulators can be identiﬁed. Start-
ing with a set of genes (or their protein products)
that may have been deduced from expression array
data, a subnetwork can be reconstructed that com-
prises a maximal number of affected molecules.
This can be visualized with PathwayBuilder,
in combination with ArrayAnalyzer, which is
a ﬁrst step towards efﬁcient drug target pre-
diction. ArrayAnalyzer is able to ﬁnd promi-
nent molecules which are highly connected to the
regulated genes. Since genes and their respec-
tive gene products (molecules) are separated in
TRANSPATH, the user can distinguish between
regulation of gene expression and protein signalling
networks. An example is given in Krull et al.[ 8 ] .
Conclusions and outlook
So far, high quality data cannot be extracted by
text mining, in particular the retrieval of species
and of experimental details. On the other hand, it
may provide higher coverage of relevant published
data and, thus, may allow us to reconstruct net-
works more comprehensively. Among the existing
databases, only a few concentrate on mammalian
species, and differentiate between gene regulation
and protein networks, as in CSNDB [14], MINT
[19] and TRANSPATH. TRANSPATH also con-
tains tools for visualization and analysis, leading to
reliable pathway and network construction.
Another point of view has been neglected so far:
the spatio-temporal speciﬁcity of cellular processes.
Reliable information about this is still sparse, but
is expected to grow with new upcoming methods.
The integration of this kind of data and their use for
a more speciﬁc visualization and prediction is a key
point for further development of TRANSPATH.
Nevertheless, common efforts are desirable and
will be necessary for creating a more comprehen-
sive multi-dimensional integration, including data
from all current databases in terms of protein inter-
action as well as signalling and metabolic path-
ways, from high-throughput assays, or data from
text mining, and even from in-silico analyses,
since different approaches and methodologies will
strengthen the knowledge of cellular processes and
thus will help to further improve our chances of
combating disease.
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